# Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

> **NCT03673527** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** topical formulation of tacrolimus

## Key facts

- **NCT ID:** NCT03673527
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-22
- **Primary completion:** 2019-02-04
- **Final completion:** 2019-02-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03673527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03673527, "Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03673527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*